NDC 33342-407-66 - Dapagliflozin and Metformin Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 33342-407
- Requested NDC
- 33342-407-66
- Package NDCs from labels
- 33342-407-07, 33342-407-09, 33342-407-10, 33342-407-15, 33342-407-66, 33342-407-06
- Manufacturer
- Macleods Pharmaceuticals Limited
- Effective date
- 2026-09-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dapagliflozin and Metformin Hydrochloride - Macleods Pharmaceuticals Limited | Macleods Pharmaceuticals Limited | 2026-09-16 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 33342-407-06 | Dapagliflozin and Metformin Hydrochloride | 3 in 1 CARTON | TABLET, EXTENDED RELEASE | 3 | 1 | |
| 33342-407-07 | Dapagliflozin and Metformin Hydrochloride | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 1 | |
| 33342-407-09 | Dapagliflozin and Metformin Hydrochloride | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 1 | |
| 33342-407-10 | Dapagliflozin and Metformin Hydrochloride | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 1 | |
| 33342-407-15 | Dapagliflozin and Metformin Hydrochloride | 500 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 500 | 1 | |
| 33342-407-66 | Dapagliflozin and Metformin Hydrochloride | 10 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 10 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 33342-407-07 | EA - Each | 33342-407 | 59052b4a-1131-48d5-9a4d-4f385fd92d20 | 1 | 2026-05-22 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ELROEL Pang Pang Sun Cushion Plus | ZINC OXIDE, TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | MONOGLOT HOLDINGS Inc. | 5ffaad65-f0b2-416a-b0a3-b92e880641e4 | 2025-09-18 | Warnings | 15FIX9V2JP |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Coupler LLC | 3eeee3b7-188a-05a0-e063-6294a90a1853 | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| CVS SPF 50 Face Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | CVS | 26a69a47-947a-a478-e063-6394a90aa468 | 2025-09-16 | Warnings | 15FIX9V2JP |
| Metformin | METFORMIN | Coupler LLC | 3edc9b51-ddee-61f8-e063-6294a90ad3c5 | 2025-09-15 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| REFRESH OPTIVE Drops | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 80275190-d717-40ea-905b-5c8fbe986eac | 2025-09-15 | Warnings | K679OBS311 |
| Refresh Relieva PF Xtra | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | b51b8a75-8faa-430f-8f7e-ee58d3d13f2e | 2025-09-15 | Warnings | K679OBS311 |
| Refresh Relieva | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 6b984fa2-4187-45ef-b7d3-15e720abc667 | 2025-09-15 | Warnings | K679OBS311 |
| Owell Naturals Draw Salve, Arnica, Silicea | ARNICA MONTANA HPUS, SILICEA HPUS | Owell Naturals Brand LLC | 1c9dab31-de1f-911b-e063-6294a90a0391 | 2025-09-12 | Warnings | ETJ7Z6XBU4 |
| Owell Naturals Draw Salve | ARNICA MONTANA HPUS, SILICEA HPUS | Owell Naturals Brand LLC | 1536ff1e-16b8-fbbc-e063-6394a90a628e | 2025-09-12 | Warnings | ETJ7Z6XBU4 |
| Lubricant Drops | CARBOXYMETHYLCELLULOSE SODIUM | CARDINAL HEALTH 110, LLC. DBA LEADER | 1ac2fe24-9ff6-48c1-b123-fbc0e48f5304 | 2025-09-12 | Warnings | K679OBS311 |
| Eyes Irritation Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | CARDINAL HEALTH 110, LLC. DBA LEADER | bd2608c6-ffdf-352a-e053-2995a90a26a8 | 2025-09-12 | Warnings | 532B59J990 |
| Dry Eye Relief | CARBOXYMETHYLCELLULOSE SODIUM | CARDINAL HEALTH 110, LLC. DBA LEADER | bd262028-32e9-052d-e053-2a95a90a5303 | 2025-09-12 | Warnings | K679OBS311 |
| sunscreen | TITANIUM DIOXIDE(NANO) | Mingyu (guangdong) Cosmetics Technology Co., Ltd | 3e6fe9f3-486b-bba7-e063-6294a90adf37 | 2025-09-10 | Warnings | 15FIX9V2JP |
| Schuessler Tissue Salts Comb 12 General Tonic | CALCAREA FLUORICA,CALCAREA PHOSPHORICA,CALCAREA SULPHURICA,FERRUM PHOSPHORICUM,KALI PHOSPHORICUM,KALI MURIATICUM,KALI SULPHURICUM,MAGNESIA PHOSPHORICA,NATRUM MURIATICUM,NATRUM PHOSPHORICUM,NATRUM SULPHURICUM,SILICEA | Martin & Pleasance Pty Ltd | 9083a01b-2fbe-4e04-9eec-bf4f65950ec7 | 2025-09-09 | Warnings | ETJ7Z6XBU4 |
| Schuessler Tissue Salts Comb 12 General Tonic | CALCAREA FLUORICA,CALCAREA PHOSPHORICA,CALCAREA SULPHURICA,FERRUM PHOSPHORICUM ,KALI PHOSPHORICUM,KALI MURIATICUM,KALI SULPHURICUM,MAGNESIA PHOSPHORICA,NATRUM MURIATICUM,NATRUM PHOSPHORICUM,NATRUM SULPHURICUM,SILICEA | Martin & Pleasance Pty Ltd | c14c79ab-85bb-45f2-83d1-1d9c298ffdfd | 2025-09-08 | Warnings | ETJ7Z6XBU4 |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 5 | ENSULIZOLE ,HOMOSALATE ,OCTINOXATE,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3dbb07e2-971c-284d-e063-6294a90a437f | 2025-09-06 | Warnings | 15FIX9V2JP |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 6 | ENSULIZOLE,HOMOSALATE ,OCTINOXATE ,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3e069cb2-c4c5-abf5-e063-6394a90a56b0 | 2025-09-06 | Warnings | 15FIX9V2JP |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b52f29-c1a0-c673-e063-6294a90a9a7a | 2025-09-05 | Warnings | 15FIX9V2JP 1K09F3G675 |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b8003f-40be-3380-e063-6294a90a4f6b | 2025-09-05 | Warnings | 15FIX9V2JP 1K09F3G675 |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30, 1 | ENSULIZOLE, HOMOSALATE, OCTINOXATE, TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 18130858-429c-4ed4-a75b-5bc014481250 | 2025-09-04 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.